Molecular Imaging of Breast Cancer With Breast PET/CT
PET is literally a molecular imaging modality. In monitoring the patient's response to a
specific chemotherapeutic regime, baseline and subsequent PET/CT scans can be used to
quantitatively determine the therapeutic effect of the regime, using the standard uptake
value (SUV), a common metric in PET imaging. The breast PET/CT system will facilitate
molecular imaging of breast cancer using a number of radiolabeled molecules, available both
commercially (18-FDG) and from the research environment.
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
End-points of this study are whether women will accept the imaging position and timing, and whether functional properties of breast cancer can be imaged with this device.
Ramsey Badawi, PhD
University of California, Davis
United States: Institutional Review Board
|UC David Medical Center||Sacramento, California 95817|